Medical Nutrition Market Size is valued at USD 13.1 Bn in 2023 and is predicted to reach USD 20.2 Bn by the year 2031 at a 5.7% CAGR during the forecast period for 2024-2031.
The escalating occurrence of malnutrition among adults and the surge in obesity rates, coupled with the increasing prevalence of chronic diseases like cancer and diabetes, are primary drivers propelling market growth. Oral clinical nutrition, comprising vitamins, proteins, and carbohydrates in various forms such as powder, liquid, and semi-solid, is witnessing significant demand for oral consumption. Leading market players in the manufacturing of oral clinical nutrition products are innovating with new flavors to improve taste, thereby expanding their customer base and boosting product sales. This, in turn, drives market demand. The increasing incidence of cancer cases has heightened the need for nutritious food, driven by the adverse effects of cancer treatment, including appetite loss and malnutrition issues among adults, such as depletion of essential body nutrition proteins and vitamins.
The Medical Nutrition market is segmented on the basis of nutrition, patient type, indication, end-user and route of administration. Nutrition type segment includes proteins, carbohydrates, multi-vitamins and antioxidants, amino acids, fibers, minerals, and other. By patient type, the market is segmented as infants, adults, and geriatric populations. By indication, the market is segmented as diabetes, cancer, gastrointestinal diseases, metabolic syndromes, and other medical disorders. By end user, the market is segmented as hospitals, home care settings, long-term care facilities, and ambulatory surgical centers. By route of administration, categorized between oral, enteral, and parenteral delivery methods.
In the medical nutrition market, the Cancer segment is anticipated to hold a dominant position based on indication. This is mainly due to the substantial prevalence of cancer globally, with it being the second leading cause of death worldwide. Cancer patients often experience various nutritional challenges, including weight loss, malnutrition, and difficulty in eating, which can negatively impact their overall health and treatment outcomes. Consequently, there is an increasing acceptance of the significance of specialized nutritional support for cancer patients in order to facilitate the efficacy of cancer treatments, manage symptoms, enhance the quality of life, and address their unique dietary requirements, including chemotherapy and radiation therapy. Consequently, the Cancer segment is anticipated to hold a notable share of the medical nutrition market as healthcare providers continue emphasising nutritional interventions as a crucial aspect of comprehensive cancer care.
In the medical nutrition market, the Geriatric Nutrition segment is poised to maintain a leading position primarily due to the significant increase in the global geriatric population. As demographics shift towards an aging population worldwide, there's a corresponding rise in the prevalence of age-related health conditions and nutritional challenges among the elderly.Geriatric individuals often face unique dietary needs and challenges due to factors such as decreased appetite, changes in metabolism, and a higher risk of chronic diseases. Consequently, there's an increased demand for specialized nutritional products and services tailored to address these specific needs and support optimal health outcomes among older adults.
The growing population of individuals affected by non-communicable diseases like diabetes, hypertension, cancer, and chronic kidney diseases (CKDs) is anticipated to drive demand for oral clinical nutritional products in this area. Additionally, the increasing efforts among pharmaceutical and food & nutrition companies to broaden their product portfolios fuel this segment's growth. The Asia Pacific region is expected to experience rapid growth during the forecast period. This can be attributed to the development of healthcare infrastructure, improved healthcare reimbursement policies, government initiatives in the healthcare sector, and favourable economic growth, all of which contribute positively to market expansion. Furthermore, the presence of prominent players in this region is a significant factor driving regional growth.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 13.1 Bn |
|
Revenue Forecast In 2031 |
USD 20.2 Bn |
|
Growth Rate CAGR |
CAGR of 5.7% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn, and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Nutrition, Patient Type, Indication, End-User And Route Of Administration |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Abbott Laboratories; Pfizer Inc.; Bayer AG; Nestle S.A.; GlaxoSmithKline plc; Baxter International Inc.; Otsuka Holdings Co.; Ltd.; Mead Johnson & Company; LLC; Danone Nutricia; Victus; Inc. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Medical nutrition Market Snapshot
Chapter 4. Global Medical nutrition Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Nutrition Type Estimates & Trend Analysis
5.1. by Nutrition Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Nutrition Type:
5.2.1. Proteins
5.2.2. Carbohydrates
5.2.3. Multivitamins & Antioxidants
5.2.4. Amino Acids
5.2.5. Fibers
5.2.6. Minerals
5.2.7. Others
Chapter 6. Market Segmentation 2: by Indication Estimates & Trend Analysis
6.1. by Indication & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Indication:
6.2.1. Diabetes
6.2.2. Cancer
6.2.3. Gastrointestinal Diseases
6.2.4. Metabolic Syndromes
6.2.5. Others
Chapter 7. Market Segmentation 3: by Patient Type Estimates & Trend Analysis
7.1. by Patient Type & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Patient Type:
7.2.1. Infant Nutrition
7.2.2. Adult Nutrition
7.2.3. Geriatric Nutrition
Chapter 8. Market Segmentation 4: by Route of Administration Estimates & Trend Analysis
8.1. by Route of Administration & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Route of Administration:
8.2.1. Oral
8.2.2. Enteral
8.2.3. Parenteral
Chapter 9. Market Segmentation 5: by End-User Estimates & Trend Analysis
9.1. by End-User & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User:
9.2.1. Hospitals
9.2.2. Home Care Settings
9.2.3. Long Term Car
9.2.4. Ambulatory Surgical Centers
Chapter 10. Medical nutrition Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Nutrition Type, 2019-2031
10.1.2. North America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.1.3. North America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2019-2031
10.1.4. North America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration,2019-2031
10.1.5. North America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.1.6. North America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.2. Europe
10.2.1. Europe Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Nutrition Type, 2019-2031
10.2.2. Europe Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.2.3. Europe Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2019-2031
10.2.4. Europe Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2019-2031
10.2.5. Europe Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.2.6. Europe Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Nutrition Type, 2019-2031
10.3.2. Asia Pacific Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.3.3. Asia-Pacific Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2019-2031
10.3.4. Asia Pacific Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration,2019-2031
10.3.5. Asia Pacific Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.3.6. Asia Pacific Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.4. Latin America
10.4.1. Latin America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Nutrition Type, 2019-2031
10.4.2. Latin America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.4.3. Latin America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2019-2031
10.4.4. Latin America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration ,2019-2031
10.4.5. Latin America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.4.6. Latin America Medical Nutrition Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Nutrition Type, 2019-2031
10.5.2. Middle East & Africa Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.5.3. Middle East & Africa Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2019-2031
10.5.4. Middle East & Africa Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2019-2031
10.5.5. Middle East & Africa Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.5.6. Middle East & Africa Medical nutrition Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Abbott
11.2.2. Danone S.A.
11.2.3. Baxter
11.2.4. Nestlé
11.2.5. GSK plc.
11.2.6. Sun Pharmaceutical Industries Ltd.
11.2.7. Sanofi
11.2.8. DSM
11.2.9. BASF SE
11.2.10. Fresenius SE & Co. KGaA
11.2.11. Leprino Foods Company
11.2.12. Fresenius Kabi Ltd
11.2.13. Sparer Onco Nutrition
11.2.14. Kate Farms
11.2.15. Guardion Health Sciences, Inc.
11.2.16. Other Prominent Players
By Patient Type:
By Indication:
By Route of Administration:
By End User:
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
